Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy.
Nagahashi M, Ishikawa E, Nagai T, Kanaoka H, Oshiro A, Togashi Y, Hattori A, Tsuchida J, Higuchi T, Nishimukai A, Murase K, Takatsuka Y, Kihara T, Ling Y, Okuda S, Hirota S, Miyoshi Y.
Nagahashi M, et al. Among authors: miyoshi y.
Breast Cancer. 2025 Jan 14. doi: 10.1007/s12282-025-01665-y. Online ahead of print.
Breast Cancer. 2025.
PMID: 39808396